Astex Therapeutics Overview

  • Founded
  • 1999
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 81
Employees
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $151M
Latest Deal Amount

Astex Therapeutics General Information

Description

Operator of a biotechnology company focused on the discovery and development of drugs in oncology and other areas. The company uses its fragment-based drug discovery technology to identify and develop new medicines, primarily for the treatment of cancer and antiviral diseases, thereby helping in optimizing the pharmacokinetic properties and safety of their lead compounds.

Contact Information

Formerly Known As
Astex Technology
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Primary Office
  • 436 Cambridge Science Park
  • Milton Road
  • Cambridge CB4 0QA
  • England, United Kingdom
+44 01223 000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Astex Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 20-Jul-2011 $151M 000.00 00000 Completed Profitable
6. Grant 02-Mar-2009 00000 000.00 Completed Profitable
5. Later Stage VC 000.00 Completed Profitable
4. Later Stage VC 05-Nov-2003 000.00 000.00 Completed Profitable
3. Early Stage VC 17-Dec-2001 00.000 000.00 Completed Product Development
2. Early Stage VC 14-May-2001 $32.5M $32.5M Completed Product Development
1. Early Stage VC 03-Dec-1999 Completed Product Development
To view Astex Therapeutics’s complete valuation and funding history, request access »

Astex Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Astex Therapeutics Former Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Abingworth Management Venture Capital Minority 000 0000 000000 0
Advent International PE/Buyout Minority 000 0000 000000 0
Alta Partners Venture Capital Minority 000 0000 000000 0
Gimv PE/Buyout Minority 000 0000 000000 0
Novartis Venture Fund Corporate Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »